

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.04555043 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.04555043 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.27796039 |
| 4 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.99446579 |
| 5 | proline biosynthetic process (GO:0006561) | 3.94204696 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 3.92066875 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.92066875 |
| 8 | regulation of cholesterol homeostasis (GO:2000188) | 3.84780760 |
| 9 | DNA unwinding involved in DNA replication (GO:0006268) | 3.83596790 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.81554837 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 3.81554837 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 3.80026527 |
| 13 | 4-hydroxyproline metabolic process (GO:0019471) | 3.79316070 |
| 14 | basement membrane organization (GO:0071711) | 3.78854891 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 3.78277253 |
| 16 | adherens junction assembly (GO:0034333) | 3.73695622 |
| 17 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.68819296 |
| 18 | protein localization to endosome (GO:0036010) | 3.68643862 |
| 19 | lysine metabolic process (GO:0006553) | 3.65224503 |
| 20 | lysine catabolic process (GO:0006554) | 3.65224503 |
| 21 | cell-substrate adherens junction assembly (GO:0007045) | 3.61408223 |
| 22 | focal adhesion assembly (GO:0048041) | 3.61408223 |
| 23 | homocysteine metabolic process (GO:0050667) | 3.60066570 |
| 24 | cell-substrate junction assembly (GO:0007044) | 3.59224327 |
| 25 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.57183333 |
| 26 | mitotic chromosome condensation (GO:0007076) | 3.55684522 |
| 27 | protein carboxylation (GO:0018214) | 3.50464376 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.50464376 |
| 29 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48329185 |
| 30 | positive regulation of nuclease activity (GO:0032075) | 3.48266554 |
| 31 | skin morphogenesis (GO:0043589) | 3.47120234 |
| 32 | cysteine metabolic process (GO:0006534) | 3.41887832 |
| 33 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.39886324 |
| 34 | hemidesmosome assembly (GO:0031581) | 3.39532028 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35359272 |
| 36 | urea cycle (GO:0000050) | 3.32865373 |
| 37 | urea metabolic process (GO:0019627) | 3.32865373 |
| 38 | COPII vesicle coating (GO:0048208) | 3.31982913 |
| 39 | complement activation, alternative pathway (GO:0006957) | 3.31047482 |
| 40 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.28226660 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 3.27646328 |
| 42 | regulation of protein activation cascade (GO:2000257) | 3.25534186 |
| 43 | regulation of translational fidelity (GO:0006450) | 3.25117974 |
| 44 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.24558475 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.24411411 |
| 46 | activation of Rac GTPase activity (GO:0032863) | 3.24054986 |
| 47 | cell adhesion mediated by integrin (GO:0033627) | 3.22471411 |
| 48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22338065 |
| 49 | regulation of early endosome to late endosome transport (GO:2000641) | 3.22123409 |
| 50 | epithelial cell-cell adhesion (GO:0090136) | 3.21735174 |
| 51 | glycine metabolic process (GO:0006544) | 3.19081218 |
| 52 | glyoxylate metabolic process (GO:0046487) | 3.18543693 |
| 53 | regulation of nuclease activity (GO:0032069) | 3.17319566 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 3.17202242 |
| 55 | negative regulation of sterol transport (GO:0032372) | 3.17202242 |
| 56 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.17000400 |
| 57 | kynurenine metabolic process (GO:0070189) | 3.16421297 |
| 58 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.14203412 |
| 59 | positive regulation of histone deacetylation (GO:0031065) | 3.13410953 |
| 60 | desmosome organization (GO:0002934) | 3.12950062 |
| 61 | regulation of complement activation (GO:0030449) | 3.10976914 |
| 62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.08715152 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 3.06614341 |
| 64 | negative regulation of cell size (GO:0045792) | 3.04683462 |
| 65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.03960990 |
| 66 | cellular response to unfolded protein (GO:0034620) | 2.98017429 |
| 67 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.96012025 |
| 68 | one-carbon metabolic process (GO:0006730) | 2.95577130 |
| 69 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.94247372 |
| 70 | tetrahydrofolate metabolic process (GO:0046653) | 2.93976211 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 2.92710310 |
| 72 | nuclear pore complex assembly (GO:0051292) | 2.92203635 |
| 73 | semaphorin-plexin signaling pathway (GO:0071526) | 2.92161793 |
| 74 | reverse cholesterol transport (GO:0043691) | 2.91286811 |
| 75 | ER-nucleus signaling pathway (GO:0006984) | 2.90856801 |
| 76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.90832613 |
| 77 | apoptotic cell clearance (GO:0043277) | 2.88749750 |
| 78 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.86226734 |
| 79 | bile acid biosynthetic process (GO:0006699) | 2.86192454 |
| 80 | maternal placenta development (GO:0001893) | 2.85838805 |
| 81 | nitrogen cycle metabolic process (GO:0071941) | 2.84745476 |
| 82 | embryonic process involved in female pregnancy (GO:0060136) | 2.84002091 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 2.83775590 |
| 84 | protein retention in ER lumen (GO:0006621) | 2.81628402 |
| 85 | protein maturation by protein folding (GO:0022417) | 2.81323056 |
| 86 | apoptotic process involved in morphogenesis (GO:0060561) | 2.81256718 |
| 87 | peptidyl-proline hydroxylation (GO:0019511) | 2.79857828 |
| 88 | glucose catabolic process (GO:0006007) | 2.78838498 |
| 89 | heterochromatin organization (GO:0070828) | 2.78357891 |
| 90 | membrane protein ectodomain proteolysis (GO:0006509) | 2.76794629 |
| 91 | endodermal cell differentiation (GO:0035987) | 2.76163882 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 2.76158742 |
| 93 | regulation of histone H3-K27 methylation (GO:0061085) | 2.75948630 |
| 94 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.75935505 |
| 95 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.75522887 |
| 96 | pore complex assembly (GO:0046931) | 2.75504133 |
| 97 | regulation of RNA export from nucleus (GO:0046831) | 2.75098844 |
| 98 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.74934194 |
| 99 | negative regulation of lipid transport (GO:0032369) | 2.74310909 |
| 100 | nuclear pore organization (GO:0006999) | 2.74067820 |
| 101 | cellular response to topologically incorrect protein (GO:0035967) | 2.72460076 |
| 102 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.72423462 |
| 103 | glucose 6-phosphate metabolic process (GO:0051156) | 2.72402812 |
| 104 | pentose-phosphate shunt (GO:0006098) | 2.72233343 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.71968145 |
| 106 | serine family amino acid metabolic process (GO:0009069) | 2.71216935 |
| 107 | epoxygenase P450 pathway (GO:0019373) | 2.70976086 |
| 108 | lipoprotein metabolic process (GO:0042157) | 2.70762867 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 2.70496903 |
| 110 | pinocytosis (GO:0006907) | 2.70403429 |
| 111 | indole-containing compound catabolic process (GO:0042436) | 2.69645605 |
| 112 | indolalkylamine catabolic process (GO:0046218) | 2.69645605 |
| 113 | tryptophan catabolic process (GO:0006569) | 2.69645605 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 2.68838434 |
| 115 | ethanol oxidation (GO:0006069) | 2.67818683 |
| 116 | tryptophan metabolic process (GO:0006568) | 2.67584243 |
| 117 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.66378111 |
| 118 | paraxial mesoderm development (GO:0048339) | 2.66259118 |
| 119 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65630335 |
| 120 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.65306095 |
| 121 | valine metabolic process (GO:0006573) | 2.65229835 |
| 122 | proline metabolic process (GO:0006560) | 2.64204838 |
| 123 | protein hydroxylation (GO:0018126) | 2.64092787 |
| 124 | stress fiber assembly (GO:0043149) | 2.63180047 |
| 125 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.61988287 |
| 126 | imidazole-containing compound metabolic process (GO:0052803) | 2.61918977 |
| 127 | tricarboxylic acid metabolic process (GO:0072350) | 2.61220898 |
| 128 | midgut development (GO:0007494) | 2.61027061 |
| 129 | convergent extension (GO:0060026) | 2.60510461 |
| 130 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.60144555 |
| 131 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.59594499 |
| 132 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.59426593 |
| 133 | protein export from nucleus (GO:0006611) | 2.59333906 |
| 134 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.58924269 |
| 135 | establishment of apical/basal cell polarity (GO:0035089) | 2.58717300 |
| 136 | triglyceride homeostasis (GO:0070328) | 2.58634494 |
| 137 | acylglycerol homeostasis (GO:0055090) | 2.58634494 |
| 138 | mRNA stabilization (GO:0048255) | 2.58583747 |
| 139 | RNA stabilization (GO:0043489) | 2.58583747 |
| 140 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.58396583 |
| 141 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58234078 |
| 142 | negative regulation of fatty acid transport (GO:2000192) | 2.57811509 |
| 143 | vesicle coating (GO:0006901) | 2.55349869 |
| 144 | cellular protein complex localization (GO:0034629) | 2.54949890 |
| 145 | bile acid metabolic process (GO:0008206) | 2.54212381 |
| 146 | intestinal absorption (GO:0050892) | 2.54036933 |
| 147 | regulation of establishment of planar polarity (GO:0090175) | 2.53521003 |
| 148 | endothelial cell morphogenesis (GO:0001886) | 2.51976329 |
| 149 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.51688984 |
| 150 | NADPH regeneration (GO:0006740) | 2.50879400 |
| 151 | tyrosine metabolic process (GO:0006570) | 2.50415301 |
| 152 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.50400742 |
| 153 | protein complex localization (GO:0031503) | 2.49255907 |
| 154 | polarized epithelial cell differentiation (GO:0030859) | 2.48601316 |
| 155 | protein-lipid complex remodeling (GO:0034368) | 2.47448509 |
| 156 | macromolecular complex remodeling (GO:0034367) | 2.47448509 |
| 157 | plasma lipoprotein particle remodeling (GO:0034369) | 2.47448509 |
| 158 | mannose metabolic process (GO:0006013) | 2.47322043 |
| 159 | regulation of hippo signaling (GO:0035330) | 2.45868386 |
| 160 | response to endoplasmic reticulum stress (GO:0034976) | 2.40861985 |
| 161 | hyaluronan catabolic process (GO:0030214) | 2.39165803 |
| 162 | response to laminar fluid shear stress (GO:0034616) | 2.38648753 |
| 163 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.36895138 |
| 164 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35769468 |
| 165 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.32712968 |
| 166 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32591602 |
| 167 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.30129803 |
| 168 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.29782261 |
| 169 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.29693256 |
| 170 | response to epidermal growth factor (GO:0070849) | 2.28382006 |
| 171 | protein localization to microtubule (GO:0035372) | 2.27579123 |
| 172 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.25714690 |
| 173 | chromosome condensation (GO:0030261) | 2.25151130 |
| 174 | embryo implantation (GO:0007566) | 2.24277859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.69224447 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96084971 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.77710762 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.50160490 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.17710920 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17088377 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.13651871 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10492505 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02789839 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.89570859 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58048770 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44909588 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.44471083 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.17470468 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08988258 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.96359664 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.91197158 |
| 18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.90356259 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90257636 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88596683 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.86756161 |
| 22 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74722710 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.69229939 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64146056 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.64091283 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63666063 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60702242 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.57243286 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54188422 |
| 30 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.54072119 |
| 31 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.53946855 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53682387 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.50229988 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49739817 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47154909 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46716711 |
| 37 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45348504 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44291837 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43562962 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41818364 |
| 41 | ATF3_27146783_Chip-Seq_COLON_Human | 1.41569348 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41080293 |
| 43 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39970017 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39790979 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.39724796 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39266645 |
| 47 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38319399 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38241375 |
| 49 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37585694 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37533556 |
| 51 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.37457616 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36571231 |
| 53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36335544 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36107589 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34974379 |
| 56 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34785989 |
| 57 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34676613 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33181122 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32228170 |
| 60 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30326508 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28623219 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27795634 |
| 63 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25886276 |
| 64 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.25489677 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25066260 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23935829 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21590322 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21354769 |
| 69 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21099646 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21077443 |
| 71 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20350618 |
| 72 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20214766 |
| 73 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19926484 |
| 74 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19304905 |
| 75 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18412995 |
| 76 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18323604 |
| 77 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17911504 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16585580 |
| 79 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16131071 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15941011 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14434127 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14379395 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14353239 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13955838 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13886758 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13400725 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12815235 |
| 88 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12283458 |
| 89 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11430712 |
| 90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09892722 |
| 91 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.08938484 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07705608 |
| 93 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07343056 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06539671 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05911427 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05731125 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05427323 |
| 98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04682382 |
| 99 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04513634 |
| 100 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04365255 |
| 101 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03464845 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02756441 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01467380 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01402512 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01339043 |
| 106 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01255253 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00927218 |
| 108 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00564792 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00560809 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00293442 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00120849 |
| 112 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99896041 |
| 113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99645007 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99456863 |
| 115 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99029589 |
| 116 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98713342 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98285224 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97463990 |
| 119 | * P68_20966046_ChIP-Seq_HELA_Human | 0.96522240 |
| 120 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96245108 |
| 121 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94951845 |
| 122 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94619057 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 0.94515239 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93769221 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93003551 |
| 126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92082934 |
| 127 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91582115 |
| 128 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90990659 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90301106 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89698711 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89589393 |
| 132 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88610276 |
| 133 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88516232 |
| 134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87806716 |
| 135 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86621894 |
| 136 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86618297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.57538458 |
| 2 | MP0005360_urolithiasis | 4.52168138 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.06243203 |
| 4 | MP0005365_abnormal_bile_salt | 2.99362194 |
| 5 | MP0003252_abnormal_bile_duct | 2.98307464 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.89436660 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.49864738 |
| 8 | MP0005257_abnormal_intraocular_pressure | 2.45934302 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.38422086 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.36277990 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.32729778 |
| 12 | MP0004858_abnormal_nervous_system | 2.32324391 |
| 13 | MP0005451_abnormal_body_composition | 2.25296813 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.14046532 |
| 15 | MP0003283_abnormal_digestive_organ | 2.06219931 |
| 16 | MP0009840_abnormal_foam_cell | 1.96293011 |
| 17 | MP0004233_abnormal_muscle_weight | 1.95959011 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.95080269 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.81618398 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80248986 |
| 21 | MP0005409_darkened_coat_color | 1.79144873 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.78083680 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.75948902 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 1.73628672 |
| 25 | MP0009384_cardiac_valve_regurgitation | 1.71514867 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.71499470 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.70614252 |
| 28 | MP0005083_abnormal_biliary_tract | 1.67238705 |
| 29 | MP0006054_spinal_hemorrhage | 1.66594608 |
| 30 | MP0009053_abnormal_anal_canal | 1.64738039 |
| 31 | MP0000537_abnormal_urethra_morphology | 1.62157108 |
| 32 | MP0004272_abnormal_basement_membrane | 1.59854582 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.55526303 |
| 34 | MP0003111_abnormal_nucleus_morphology | 1.48873743 |
| 35 | MP0001348_abnormal_lacrimal_gland | 1.48076101 |
| 36 | MP0000609_abnormal_liver_physiology | 1.47715039 |
| 37 | MP0002796_impaired_skin_barrier | 1.46303560 |
| 38 | MP0005023_abnormal_wound_healing | 1.35945054 |
| 39 | MP0001849_ear_inflammation | 1.28344235 |
| 40 | MP0004197_abnormal_fetal_growth/weight/ | 1.27791945 |
| 41 | MP0000858_altered_metastatic_potential | 1.27493288 |
| 42 | MP0005501_abnormal_skin_physiology | 1.26320850 |
| 43 | MP0005220_abnormal_exocrine_pancreas | 1.25398775 |
| 44 | MP0000566_synostosis | 1.24338908 |
| 45 | MP0005332_abnormal_amino_acid | 1.23261335 |
| 46 | MP0008260_abnormal_autophagy | 1.22874542 |
| 47 | MP0002089_abnormal_postnatal_growth/wei | 1.22358415 |
| 48 | MP0003941_abnormal_skin_development | 1.21030893 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.17481863 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.16384989 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.15995488 |
| 52 | MP0002896_abnormal_bone_mineralization | 1.15016807 |
| 53 | MP0010307_abnormal_tumor_latency | 1.13111283 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.12066341 |
| 55 | MP0000751_myopathy | 1.11814016 |
| 56 | MP0005621_abnormal_cell_physiology | 1.08776009 |
| 57 | MP0005275_abnormal_skin_tensile | 1.08004748 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.07902800 |
| 59 | MP0001915_intracranial_hemorrhage | 1.07399749 |
| 60 | MP0008932_abnormal_embryonic_tissue | 1.06305107 |
| 61 | MP0003115_abnormal_respiratory_system | 1.06108748 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.05990186 |
| 63 | MP0010030_abnormal_orbit_morphology | 1.05544121 |
| 64 | MP0000598_abnormal_liver_morphology | 1.04858662 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 1.04473033 |
| 66 | MP0003868_abnormal_feces_composition | 1.04323284 |
| 67 | MP0003385_abnormal_body_wall | 1.01863468 |
| 68 | MP0003045_fibrosis | 1.01752697 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.01051981 |
| 70 | MP0001730_embryonic_growth_arrest | 1.00161991 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 0.99325112 |
| 72 | MP0000762_abnormal_tongue_morphology | 0.99304176 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 0.98972108 |
| 74 | MP0000467_abnormal_esophagus_morphology | 0.98756494 |
| 75 | MP0000579_abnormal_nail_morphology | 0.98303140 |
| 76 | MP0003693_abnormal_embryo_hatching | 0.96516571 |
| 77 | MP0002396_abnormal_hematopoietic_system | 0.95893353 |
| 78 | MP0005508_abnormal_skeleton_morphology | 0.94599263 |
| 79 | MP0003329_amyloid_beta_deposits | 0.94323415 |
| 80 | MP0009672_abnormal_birth_weight | 0.94136699 |
| 81 | MP0001216_abnormal_epidermal_layer | 0.93322957 |
| 82 | MP0003091_abnormal_cell_migration | 0.92706205 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.92618631 |
| 84 | MP0002084_abnormal_developmental_patter | 0.92311817 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.91644079 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.91632054 |
| 87 | MP0000428_abnormal_craniofacial_morphol | 0.90754696 |
| 88 | MP0000733_abnormal_muscle_development | 0.90487646 |
| 89 | MP0003984_embryonic_growth_retardation | 0.90439460 |
| 90 | MP0003123_paternal_imprinting | 0.89188312 |
| 91 | MP0003195_calcinosis | 0.88151094 |
| 92 | MP0002928_abnormal_bile_duct | 0.87967258 |
| 93 | MP0001672_abnormal_embryogenesis/_devel | 0.87853209 |
| 94 | MP0005380_embryogenesis_phenotype | 0.87853209 |
| 95 | MP0000462_abnormal_digestive_system | 0.87005320 |
| 96 | MP0003077_abnormal_cell_cycle | 0.86664306 |
| 97 | MP0010630_abnormal_cardiac_muscle | 0.84872078 |
| 98 | MP0002168_other_aberrant_phenotype | 0.84790595 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.84708673 |
| 100 | MP0003942_abnormal_urinary_system | 0.84335209 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.84302033 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.83489040 |
| 103 | MP0003119_abnormal_digestive_system | 0.83426562 |
| 104 | MP0001243_abnormal_dermal_layer | 0.83388805 |
| 105 | MP0003279_aneurysm | 0.83345224 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.82769134 |
| 107 | MP0002697_abnormal_eye_size | 0.81817670 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.80987418 |
| 109 | MP0002092_abnormal_eye_morphology | 0.80446803 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.80431824 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.80222552 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.79129811 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.78509077 |
| 114 | MP0000627_abnormal_mammary_gland | 0.77555873 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.77301308 |
| 116 | MP0002085_abnormal_embryonic_tissue | 0.77137914 |
| 117 | MP0009931_abnormal_skin_appearance | 0.76616735 |
| 118 | MP0004947_skin_inflammation | 0.76550630 |
| 119 | MP0001697_abnormal_embryo_size | 0.76497274 |
| 120 | MP0002925_abnormal_cardiovascular_devel | 0.75976592 |
| 121 | MP0002254_reproductive_system_inflammat | 0.75356758 |
| 122 | MP0004957_abnormal_blastocyst_morpholog | 0.75144937 |
| 123 | MP0005384_cellular_phenotype | 0.74554539 |
| 124 | MP0009278_abnormal_bone_marrow | 0.73305655 |
| 125 | MP0002060_abnormal_skin_morphology | 0.72877976 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.72721595 |
| 127 | MP0002080_prenatal_lethality | 0.72471437 |
| 128 | MP0001661_extended_life_span | 0.71378380 |
| 129 | MP0009703_decreased_birth_body | 0.70649761 |
| 130 | MP0001958_emphysema | 0.70407030 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.69966372 |
| 132 | MP0005187_abnormal_penis_morphology | 0.69939910 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.69486531 |
| 134 | MP0000534_abnormal_ureter_morphology | 0.68731928 |
| 135 | MP0000350_abnormal_cell_proliferation | 0.67877609 |
| 136 | MP0002111_abnormal_tail_morphology | 0.66697731 |
| 137 | MP0002282_abnormal_trachea_morphology | 0.66026544 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.65718186 |
| 139 | MP0005670_abnormal_white_adipose | 0.65285517 |
| 140 | MP0002932_abnormal_joint_morphology | 0.64436961 |
| 141 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64176178 |
| 142 | MP0005503_abnormal_tendon_morphology | 0.63755686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.41226022 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 3.50742458 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.48286872 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.38087709 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.28356310 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.19540433 |
| 7 | Xanthomatosis (HP:0000991) | 3.16508876 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.07391680 |
| 9 | Abnormality of the intrinsic pathway (HP:0010989) | 2.98633226 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.84861894 |
| 11 | Spastic diplegia (HP:0001264) | 2.76057339 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 2.73517645 |
| 13 | Complement deficiency (HP:0004431) | 2.68906752 |
| 14 | Broad face (HP:0000283) | 2.67698291 |
| 15 | Back pain (HP:0003418) | 2.65596986 |
| 16 | Pseudobulbar signs (HP:0002200) | 2.65495585 |
| 17 | Fragile skin (HP:0001030) | 2.61729589 |
| 18 | Aneurysm (HP:0002617) | 2.59079560 |
| 19 | Atrophic scars (HP:0001075) | 2.57333104 |
| 20 | Cervical subluxation (HP:0003308) | 2.54244794 |
| 21 | Shallow orbits (HP:0000586) | 2.50602649 |
| 22 | Hand muscle atrophy (HP:0009130) | 2.50505206 |
| 23 | Hypoglycemic coma (HP:0001325) | 2.50447148 |
| 24 | Ankle contracture (HP:0006466) | 2.50251791 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46218969 |
| 26 | Wormian bones (HP:0002645) | 2.45794843 |
| 27 | Arterial tortuosity (HP:0005116) | 2.45135127 |
| 28 | Insomnia (HP:0100785) | 2.42704498 |
| 29 | Premature rupture of membranes (HP:0001788) | 2.40583481 |
| 30 | Lymphangioma (HP:0100764) | 2.40028966 |
| 31 | Spinal rigidity (HP:0003306) | 2.38384250 |
| 32 | Asymmetry of the thorax (HP:0001555) | 2.38000443 |
| 33 | Achilles tendon contracture (HP:0001771) | 2.37126653 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36540812 |
| 35 | Osteolytic defects of the hand bones (HP:0009699) | 2.36540812 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.36098376 |
| 37 | Vascular tortuosity (HP:0004948) | 2.34183820 |
| 38 | Mitral valve prolapse (HP:0001634) | 2.33360742 |
| 39 | Abnormality of dentin (HP:0010299) | 2.33173315 |
| 40 | Ankyloglossia (HP:0010296) | 2.33106169 |
| 41 | Short nail (HP:0001799) | 2.31353610 |
| 42 | Biconcave vertebral bodies (HP:0004586) | 2.30235511 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.29106954 |
| 44 | Abnormality of oral frenula (HP:0000190) | 2.27767365 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.27368667 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.23693091 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.23693091 |
| 48 | Ulnar bowing (HP:0003031) | 2.21030473 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 2.20642013 |
| 50 | Hyperacusis (HP:0010780) | 2.20575777 |
| 51 | Abnormal cartilage morphology (HP:0002763) | 2.19547900 |
| 52 | Increased connective tissue (HP:0009025) | 2.19257538 |
| 53 | Skin nodule (HP:0200036) | 2.18242514 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.18115057 |
| 55 | Aortic aneurysm (HP:0004942) | 2.17485747 |
| 56 | Ketosis (HP:0001946) | 2.16505293 |
| 57 | Renovascular hypertension (HP:0100817) | 2.12397889 |
| 58 | Abnormality of complement system (HP:0005339) | 2.11741908 |
| 59 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.10839387 |
| 60 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.09262595 |
| 61 | Long palpebral fissure (HP:0000637) | 2.07434600 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.06459754 |
| 63 | Advanced eruption of teeth (HP:0006288) | 2.06099121 |
| 64 | Flat acetabular roof (HP:0003180) | 2.04206107 |
| 65 | Abnormality of the acetabulum (HP:0003170) | 2.03383905 |
| 66 | Prolonged partial thromboplastin time (HP:0003645) | 2.03092886 |
| 67 | Myocardial infarction (HP:0001658) | 2.02978807 |
| 68 | Peritonitis (HP:0002586) | 2.02664984 |
| 69 | Turricephaly (HP:0000262) | 2.02292136 |
| 70 | Elbow flexion contracture (HP:0002987) | 2.00412657 |
| 71 | Epidermoid cyst (HP:0200040) | 2.00320044 |
| 72 | Syringomyelia (HP:0003396) | 1.98768953 |
| 73 | Spinal cord lesions (HP:0100561) | 1.98768953 |
| 74 | Bowel diverticulosis (HP:0005222) | 1.98453697 |
| 75 | Trismus (HP:0000211) | 1.97832200 |
| 76 | Mitral regurgitation (HP:0001653) | 1.97521064 |
| 77 | Selective tooth agenesis (HP:0001592) | 1.97460590 |
| 78 | Bladder diverticulum (HP:0000015) | 1.95957279 |
| 79 | Natal tooth (HP:0000695) | 1.95691273 |
| 80 | Esophageal varix (HP:0002040) | 1.94062592 |
| 81 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91814020 |
| 82 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91814020 |
| 83 | Renal duplication (HP:0000075) | 1.91363018 |
| 84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.90110698 |
| 85 | Subacute progressive viral hepatitis (HP:0006572) | 1.89672806 |
| 86 | Abnormal ossification of hand bones (HP:0005921) | 1.89561182 |
| 87 | Ketoacidosis (HP:0001993) | 1.88991987 |
| 88 | Hypercholesterolemia (HP:0003124) | 1.88521278 |
| 89 | Joint laxity (HP:0001388) | 1.88457527 |
| 90 | Macroorchidism (HP:0000053) | 1.87301926 |
| 91 | Hyperammonemia (HP:0001987) | 1.87160869 |
| 92 | Dilatation of the ascending aorta (HP:0005111) | 1.87049225 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85630940 |
| 94 | Hypoglycemic seizures (HP:0002173) | 1.84204187 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83424687 |
| 96 | Metaphyseal cupping (HP:0003021) | 1.83314433 |
| 97 | Hyperlipoproteinemia (HP:0010980) | 1.82856503 |
| 98 | Long toe (HP:0010511) | 1.82808695 |
| 99 | Patellar dislocation (HP:0002999) | 1.82059690 |
| 100 | Abnormality of the calcaneus (HP:0008364) | 1.81867045 |
| 101 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.81746834 |
| 102 | Short 4th metacarpal (HP:0010044) | 1.81746834 |
| 103 | Vertebral clefting (HP:0008428) | 1.81095915 |
| 104 | Arnold-Chiari malformation (HP:0002308) | 1.80659830 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 1.80052361 |
| 106 | Camptodactyly of toe (HP:0001836) | 1.80040845 |
| 107 | Radial bowing (HP:0002986) | 1.79999723 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79716477 |
| 109 | Abnormality of the 4th metacarpal (HP:0010012) | 1.79391784 |
| 110 | Exostoses (HP:0100777) | 1.79387902 |
| 111 | Abnormality of carpal bone ossification (HP:0006257) | 1.78931799 |
| 112 | Hyperextensible skin (HP:0000974) | 1.78181350 |
| 113 | Thin bony cortex (HP:0002753) | 1.77880478 |
| 114 | Abnormality of the lower motor neuron (HP:0002366) | 1.77713539 |
| 115 | Coxa vara (HP:0002812) | 1.77687946 |
| 116 | Breech presentation (HP:0001623) | 1.77349355 |
| 117 | Broad metatarsal (HP:0001783) | 1.76871373 |
| 118 | Elfin facies (HP:0004428) | 1.76681564 |
| 119 | Hyperglycinuria (HP:0003108) | 1.75700787 |
| 120 | Premature skin wrinkling (HP:0100678) | 1.75684958 |
| 121 | Abnormal delivery (HP:0001787) | 1.74662191 |
| 122 | Blue sclerae (HP:0000592) | 1.73336463 |
| 123 | Aortic dissection (HP:0002647) | 1.72954151 |
| 124 | Bowed forearm bones (HP:0003956) | 1.72175577 |
| 125 | Bowing of the arm (HP:0006488) | 1.72175577 |
| 126 | Mitral stenosis (HP:0001718) | 1.72005953 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.71102320 |
| 128 | Hydroxyprolinuria (HP:0003080) | 1.70899380 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 1.70899380 |
| 130 | Abnormality of glycine metabolism (HP:0010895) | 1.70669512 |
| 131 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70669512 |
| 132 | Relative macrocephaly (HP:0004482) | 1.68955894 |
| 133 | Fat malabsorption (HP:0002630) | 1.68855046 |
| 134 | Soft skin (HP:0000977) | 1.68700079 |
| 135 | Overriding aorta (HP:0002623) | 1.68635529 |
| 136 | Ependymoma (HP:0002888) | 1.68587050 |
| 137 | Hallux valgus (HP:0001822) | 1.68247437 |
| 138 | Cupped ribs (HP:0000887) | 1.67977419 |
| 139 | Deviation of the thumb (HP:0009603) | 1.67933908 |
| 140 | Ectopia lentis (HP:0001083) | 1.66291000 |
| 141 | Deviation of the hallux (HP:0010051) | 1.66235400 |
| 142 | Abnormal foot bone ossification (HP:0010675) | 1.66235173 |
| 143 | Disproportionate tall stature (HP:0001519) | 1.65882484 |
| 144 | Hemorrhage of the eye (HP:0011885) | 1.65800829 |
| 145 | Glomerulosclerosis (HP:0000096) | 1.65448668 |
| 146 | Late onset (HP:0003584) | 1.64997875 |
| 147 | Focal segmental glomerulosclerosis (HP:0000097) | 1.64966945 |
| 148 | Abnormality of the thoracic spine (HP:0100711) | 1.64686456 |
| 149 | Neonatal short-limb short stature (HP:0008921) | 1.64095102 |
| 150 | Abnormal gallbladder physiology (HP:0012438) | 1.62960948 |
| 151 | Cholecystitis (HP:0001082) | 1.62960948 |
| 152 | Genu recurvatum (HP:0002816) | 1.62467168 |
| 153 | Rectal prolapse (HP:0002035) | 1.62177877 |
| 154 | Lower limb amyotrophy (HP:0007210) | 1.62136475 |
| 155 | Distal lower limb muscle weakness (HP:0009053) | 1.62107469 |
| 156 | Gout (HP:0001997) | 1.62083818 |
| 157 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61731378 |
| 158 | Mucopolysacchariduria (HP:0008155) | 1.61731378 |
| 159 | Insidious onset (HP:0003587) | 1.61633835 |
| 160 | Termporal pattern (HP:0011008) | 1.61633835 |
| 161 | Hyperglycinemia (HP:0002154) | 1.61127007 |
| 162 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.60126481 |
| 163 | Thin ribs (HP:0000883) | 1.59515189 |
| 164 | Dislocated radial head (HP:0003083) | 1.57709325 |
| 165 | Increased nuchal translucency (HP:0010880) | 1.57618616 |
| 166 | Delayed cranial suture closure (HP:0000270) | 1.57182207 |
| 167 | Reticulocytosis (HP:0001923) | 1.56220141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.51228116 |
| 2 | PKN2 | 3.64800145 |
| 3 | SMG1 | 3.60961157 |
| 4 | ERN1 | 3.50878790 |
| 5 | EEF2K | 3.25171634 |
| 6 | SIK1 | 2.82063862 |
| 7 | CDK12 | 2.74278668 |
| 8 | PTK6 | 2.68959823 |
| 9 | MAP3K10 | 2.53581934 |
| 10 | PDGFRA | 2.36573685 |
| 11 | PRPF4B | 2.33073612 |
| 12 | IRAK3 | 2.31035353 |
| 13 | RIPK1 | 2.10437518 |
| 14 | LATS1 | 2.00862237 |
| 15 | FLT3 | 1.84962525 |
| 16 | FGFR4 | 1.84358399 |
| 17 | TAOK3 | 1.81380919 |
| 18 | TTN | 1.72121042 |
| 19 | PASK | 1.68479794 |
| 20 | EPHA2 | 1.65303779 |
| 21 | SCYL2 | 1.60345573 |
| 22 | BCKDK | 1.59268722 |
| 23 | EPHA3 | 1.51037641 |
| 24 | STK10 | 1.51012277 |
| 25 | DDR2 | 1.48796260 |
| 26 | PAK4 | 1.47249875 |
| 27 | LRRK2 | 1.45599081 |
| 28 | NME2 | 1.42616712 |
| 29 | MTOR | 1.39241826 |
| 30 | CDK6 | 1.30858198 |
| 31 | PTK2 | 1.28703018 |
| 32 | CAMK1D | 1.23265220 |
| 33 | LMTK2 | 1.19398312 |
| 34 | NEK1 | 1.16098311 |
| 35 | ICK | 1.13474963 |
| 36 | MET | 1.11059503 |
| 37 | NEK2 | 1.10904968 |
| 38 | PAK2 | 1.07957083 |
| 39 | ALK | 1.07405017 |
| 40 | RPS6KB2 | 1.02881243 |
| 41 | CDK4 | 1.02585386 |
| 42 | MAP3K8 | 1.01853264 |
| 43 | BMX | 1.01711418 |
| 44 | FRK | 0.99442195 |
| 45 | EPHB1 | 0.94862168 |
| 46 | STK3 | 0.94443726 |
| 47 | CDC7 | 0.90742624 |
| 48 | BRD4 | 0.89074175 |
| 49 | ERBB2 | 0.89024713 |
| 50 | FGFR1 | 0.85403790 |
| 51 | TAOK2 | 0.84909895 |
| 52 | ARAF | 0.84027479 |
| 53 | MAP3K13 | 0.83904407 |
| 54 | EPHB2 | 0.83626966 |
| 55 | PDGFRB | 0.81871986 |
| 56 | MAP3K7 | 0.81719683 |
| 57 | TGFBR1 | 0.80634365 |
| 58 | FGFR3 | 0.79699667 |
| 59 | TTK | 0.78851232 |
| 60 | CAMK1G | 0.77206544 |
| 61 | GRK6 | 0.77002424 |
| 62 | RET | 0.74951007 |
| 63 | PRKD2 | 0.73973638 |
| 64 | TGFBR2 | 0.73492184 |
| 65 | MAP3K2 | 0.69347222 |
| 66 | FGFR2 | 0.68900175 |
| 67 | MAP2K3 | 0.67832555 |
| 68 | KSR2 | 0.67155352 |
| 69 | EIF2AK1 | 0.66515256 |
| 70 | TYRO3 | 0.66273187 |
| 71 | NTRK1 | 0.66207608 |
| 72 | DYRK1B | 0.64726643 |
| 73 | LATS2 | 0.64486218 |
| 74 | MAPK11 | 0.63827319 |
| 75 | JAK2 | 0.62570895 |
| 76 | CLK1 | 0.60792046 |
| 77 | PRKCH | 0.59767380 |
| 78 | CDK8 | 0.58984523 |
| 79 | FER | 0.58720541 |
| 80 | JAK1 | 0.57279020 |
| 81 | MOS | 0.56947142 |
| 82 | GSK3A | 0.56422989 |
| 83 | RPS6KA4 | 0.55632124 |
| 84 | MST1R | 0.55398832 |
| 85 | CDK9 | 0.54837789 |
| 86 | PDPK1 | 0.53524915 |
| 87 | PRKD3 | 0.52438036 |
| 88 | BRAF | 0.52414769 |
| 89 | LIMK1 | 0.52357536 |
| 90 | MARK2 | 0.50467379 |
| 91 | MELK | 0.50015794 |
| 92 | MAP3K6 | 0.49205072 |
| 93 | MAP3K9 | 0.49117948 |
| 94 | MAP3K1 | 0.48700386 |
| 95 | PAK3 | 0.46485781 |
| 96 | NEK9 | 0.46429369 |
| 97 | MAP3K3 | 0.46099017 |
| 98 | ERBB4 | 0.45771122 |
| 99 | HIPK2 | 0.45655022 |
| 100 | STK38 | 0.45521815 |
| 101 | BRSK1 | 0.45426144 |
| 102 | CDK7 | 0.44662238 |
| 103 | JAK3 | 0.42613457 |
| 104 | TYK2 | 0.42381338 |
| 105 | RPS6KL1 | 0.41612237 |
| 106 | RPS6KC1 | 0.41612237 |
| 107 | TESK1 | 0.40666726 |
| 108 | CSK | 0.40295615 |
| 109 | CDC42BPA | 0.40067256 |
| 110 | PRKG2 | 0.39704427 |
| 111 | MAP2K2 | 0.39250286 |
| 112 | MAP3K14 | 0.39183368 |
| 113 | CHEK1 | 0.39174633 |
| 114 | AKT2 | 0.38199156 |
| 115 | INSRR | 0.38085618 |
| 116 | CHEK2 | 0.37896918 |
| 117 | TESK2 | 0.37764253 |
| 118 | CDK15 | 0.35790191 |
| 119 | CDK11A | 0.35673164 |
| 120 | RPS6KA2 | 0.35220479 |
| 121 | SIK3 | 0.35193244 |
| 122 | TRPM7 | 0.34931039 |
| 123 | ATR | 0.34465999 |
| 124 | AURKB | 0.34126113 |
| 125 | EGFR | 0.33441697 |
| 126 | ILK | 0.33018512 |
| 127 | KDR | 0.32016978 |
| 128 | CDK18 | 0.31946697 |
| 129 | PIM2 | 0.31359294 |
| 130 | CDK2 | 0.31287389 |
| 131 | INSR | 0.31224509 |
| 132 | MAPKAPK2 | 0.30787052 |
| 133 | ROCK2 | 0.30731796 |
| 134 | CSF1R | 0.30228790 |
| 135 | MAP2K1 | 0.29731019 |
| 136 | ITK | 0.29669724 |
| 137 | AURKA | 0.29540528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46797087 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.90331303 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83306698 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60299446 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29182955 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27104331 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18732815 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.11932706 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07446818 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04983407 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.02793636 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01446437 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.93668812 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.91326018 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.78074800 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76317553 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75469579 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71647385 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71642838 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61621897 |
| 21 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.60002788 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.54323621 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52307576 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.47761353 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47578205 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47225868 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43967318 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38487331 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37891667 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34902735 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34012461 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.31390476 |
| 33 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.30696247 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20464907 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20341070 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20242612 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19690449 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18485281 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.15368793 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.15206822 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.12428487 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11913626 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11394982 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.04766103 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03063550 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03045743 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02679638 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 1.02040654 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01932091 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.01876390 |
| 51 | Cell cycle_Homo sapiens_hsa04110 | 0.99283488 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.97765440 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97104403 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96636939 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94078421 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93946338 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93168957 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92758865 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92729681 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92339576 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90858872 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89565853 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89552539 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89187252 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.88642519 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88463512 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88227854 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87449298 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.86667134 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.86664908 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86180771 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86120115 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86037032 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85140327 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83111621 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82161256 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.80838704 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.80578684 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80535401 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80477407 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79627090 |
| 82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78208747 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77144581 |
| 84 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.77100825 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.75858217 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74791137 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73400332 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73354445 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72157977 |
| 90 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71958117 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71133925 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70296753 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69448469 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.68764859 |
| 95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67924799 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.67688976 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67570821 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65706627 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63887841 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63711189 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63696511 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63388351 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63181233 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62509654 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62103339 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62023928 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.61462354 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60783805 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60616520 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60208947 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59938329 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.59718315 |
| 113 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59383014 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59015675 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58268698 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57895918 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.57728001 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.56421229 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56194991 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.54977105 |
| 121 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54398589 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53673409 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.53010058 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52855303 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52318433 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50861658 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50700349 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49756086 |
| 129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49421582 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48374612 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47948053 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.47887676 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47753636 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.46716159 |
| 135 | Base excision repair_Homo sapiens_hsa03410 | 0.46675256 |
| 136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46573984 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46041525 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45742829 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.45433804 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45144645 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45080150 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.44959523 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43604090 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42668197 |
| 145 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.42233283 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41549383 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36693061 |
| 148 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36658370 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36439068 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35563723 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32629878 |

